| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10052282 | The Journal of Urology | 2005 | 5 Pages |
Abstract
In the largest prospective, randomized clinical trial reported to date with intravesical vanilloid therapy, single administration of RTX at doses of 0.01 μM to 0.10 μM was not effective in patients with interstitial cystitis.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
CHRISTOPHER K. PAYNE, PHILIP G. MOSBAUGH, JOHN B. FORREST, ROBERT J. EVANS, KRISTENE E. WHITMORE, JOSEPH P. ANTOCI, RAMON PEREZ-MARRERO, KARNY JACOBY, ANANIAS C. DIOKNO, KEITH J. O'REILLY, TOMAS L. GRIEBLING, SANDIP P. VASAVADA, ALBERT S. YU,